The summarized of EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.

Suppr

超能文献

作者信息

Idilman Ramazan

机构信息

Department of Gastroenterology, Ankara University School of Medicine, Ankara, Turkey.

出版信息

Turk J Gastroenterol. 2017 Sep;28(5):412-416. doi: 10.5152/tjg.2017.20817.

DOI:10.5152/tjg.2017.20817

PMID:28936972

Abstract

摘要

相似文献

The summarized of EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.

Turk J Gastroenterol. 2017 Sep;28(5):412-416. doi: 10.5152/tjg.2017.20817.

Peginterferon and lamivudine for hepatitis B.

N Engl J Med. 2004 Dec 30;351(27):2879; author reply 2879. doi: 10.1056/NEJM200412303512720.

Prevalence, incidence, and clinical relevance of the reverse transcriptase V207I mutation outside the YMDD motif of the hepatitis B virus polymerase during lamivudine therapy.

J Clin Microbiol. 2005 May;43(5):2503-5. doi: 10.1128/JCM.43.5.2503-2505.2005.

Prophylaxis, diagnosis and therapy of hepatitis B virus (HBV) infection: the German guidelines for the management of HBV infection.

Z Gastroenterol. 2007 Dec;45(12):1281-328. doi: 10.1055/s-2007-963714.

Occult hepatitis B virus infection in patients with chronic hepatitis C: An actor behind the scene or just a bystander?

J Gastroenterol Hepatol. 2010 Feb;25(2):221-3. doi: 10.1111/j.1440-1746.2009.06134.x.

Hepatitis B viral kinetics: a dynamic puzzle still to be resolved.

Hepatology. 2005 Aug;42(2):249-54. doi: 10.1002/hep.20831.

Treatment of HBeAg-positive hepatitis B with peginterferon and lamivudine.

N Engl J Med. 2005 Oct 13;353(15):1630-1; author reply 1630-1. doi: 10.1056/NEJMc052065.

Prolonged interferon-alpha therapy of hepatitis B virus-related decompensated cirrhosis.

J Viral Hepat. 1997;4 Suppl 1:21-6. doi: 10.1111/j.1365-2893.1997.tb00156.x.

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

J Hepatol. 2009 Feb;50(2):227-42. doi: 10.1016/j.jhep.2008.10.001. Epub 2008 Oct 29.

Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting.

Dig Liver Dis. 2010 Feb;42(2):81-91. doi: 10.1016/j.dld.2009.08.001. Epub 2009 Sep 11.

引用本文的文献

Reducing infection risk in multiple sclerosis and neuromyelitis optica spectrum disorders: a Brazilian reference center's approach.

Arq Neuropsiquiatr. 2022 Oct;80(10):1057-1066. doi: 10.1055/s-0042-1754348. Epub 2022 Oct 4.

Late Hepatitis B reactivation after treatment with rituximab.

IDCases. 2022 Jan 10;27:e01393. doi: 10.1016/j.idcr.2022.e01393. eCollection 2022.

Nanomedicine based approaches for combating viral infections.

J Control Release. 2021 Oct 10;338:80-104. doi: 10.1016/j.jconrel.2021.08.011. Epub 2021 Aug 8.

Negative conversion of autoantibody profile in chronic hepatitis B: A case report.

World J Clin Cases. 2021 Feb 16;9(5):1196-1203. doi: 10.12998/wjcc.v9.i5.1196.

Clinical Characteristics of Hepatitis B Virus Patients After Switching to Tenofovir Alafenamide Fumarate: A Retrospective Observational Study.

Cureus. 2020 Sep 11;12(9):e10380. doi: 10.7759/cureus.10380.

The association of hepatitis B virus screening and antiviral prophylaxis with adverse liver outcomes in Chinese cancer patients undergoing chemotherapy: A retrospective study.

Medicine (Baltimore). 2020 Apr;99(14):e19647. doi: 10.1097/MD.0000000000019647.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验